Strongbridge Bio Ord (SBBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SBBP | BMY | AMGN | GILD | REGN |
| Company | Strongbridge Bio Ord | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Regeneron Pharmaceuticals |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 1.96 | 47.93 | 265.64 | 67.01 | 901.26 |
| High | 2.06 | 48.41 | 265.92 | 67.01 | 907.16 |
| Low | 1.95 | 47.62 | 262.68 | 65.90 | 891.67 |
| Last | 2.00 | 48.30 | 262.68 | 66.16 | 893.99 |
| Change | +0.03 | +0.46 | -1.39 | -0.77 | -7.20 |
| % Change | +1.52% | +0.96% | -0.53% | -1.15% | -0.80% |
| Volume | 684,600 | 10,913,291 | 1,983,964 | 6,391,625 | 432,392 |
| 20-Day Average Volume | 234,660 | 11,419,092 | 2,196,963 | 6,212,381 | 433,155 |
| Previous Close | 1.97 | 47.84 | 264.07 | 66.93 | 901.19 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 2.10 | 50.99 | 272.96 | 70.21 | 938.74 |
| 20-Day Raw Stochastic | 13.51% | 9.85% | 0.00% | 3.10% | 4.01% |
| 20-Day Relative Strength | 42.28% | 37.48% | 36.59% | 27.91% | 33.38% |
| Weighted Alpha | -28.48 | -30.16 | +4.22 | -25.27 | +11.94 |
| Today's Opinion | 100% Sell | 72% Sell | 56% Sell | 100% Sell | 24% Buy |
| Previous Opinion | 100% Sell | 56% Sell | 56% Sell | 100% Sell | 24% Buy |
| Last Month's Opinion | 88% Sell | 24% Sell | 8% Sell | 88% Sell | 80% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.91% since 09/28/21 | -1.67% since 04/11/24 | -2.71% since 04/11/24 | -3.63% since 04/11/24 | -2.86% since 04/11/24 |
| Low | 1.95 on 10/05/21 | 47.63 on 04/18/24 | 262.68 on 04/18/24 | 65.90 on 04/18/24 | 890.43 on 04/16/24 |
| High | 2.11 on 09/29/21 | 49.10 on 04/15/24 | 270.93 on 04/15/24 | 68.62 on 04/12/24 | 921.12 on 04/15/24 |
| 1-Month | |||||
| %Chg | -10.71% since 09/03/21 | -6.38% since 03/18/24 | -3.03% since 03/18/24 | -9.69% since 03/18/24 | -6.87% since 03/18/24 |
| Low | 1.95 on 10/05/21 | 47.63 on 04/18/24 | 262.68 on 04/18/24 | 65.90 on 04/18/24 | 890.43 on 04/16/24 |
| High | 2.32 on 09/10/21 | 54.47 on 03/28/24 | 288.57 on 03/28/24 | 74.28 on 03/21/24 | 979.26 on 03/21/24 |
| 3-Month | |||||
| %Chg | -35.06% since 07/02/21 | -3.57% since 01/18/24 | -13.73% since 01/18/24 | -23.43% since 01/18/24 | -3.87% since 01/18/24 |
| Low | 1.85 on 08/16/21 | 47.58 on 02/06/24 | 262.68 on 04/18/24 | 65.90 on 04/18/24 | 890.43 on 04/16/24 |
| High | 3.19 on 07/06/21 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 998.33 on 02/28/24 |
| 6-Month | |||||
| %Chg | -28.06% since 04/05/21 | -15.04% since 10/18/23 | -7.37% since 10/18/23 | -16.96% since 10/18/23 | +8.23% since 10/18/23 |
| Low | 1.85 on 08/16/21 | 47.58 on 02/06/24 | 249.70 on 10/31/23 | 65.90 on 04/18/24 | 769.19 on 10/27/23 |
| High | 3.19 on 07/06/21 | 57.09 on 10/20/23 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 998.33 on 02/28/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 135,658 | 96,960,152 | 141,520,144 | 83,333,008 | 98,916,416 |
| Shares Outstanding, K | 67,829 | 2,026,759 | 535,919 | 1,245,077 | 109,762 |
| Annual Sales | 30,730,000 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 | 13,117,200,000 |
| Annual Net Income | -45,080,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 | 3,953,600,000 |
| Last Quarter Sales | 10,040,000 | 11,477,000,000 | 8,196,000,000 | 7,114,000,000 | 3,434,300,000 |
| Last Quarter Net Income | -13,240,000 | 1,762,000,000 | 767,000,000 | 1,429,000,000 | 1,159,600,000 |
| 60-Month Beta | 1.59 | 0.39 | 0.58 | 0.19 | 0.11 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A on 08/05/21 | 1.70 on 02/02/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 11.86 on 02/02/24 |
| Latest Earnings Date | 11/04/21 | 04/25/24 | 05/02/24 | 04/25/24 | 05/02/24 |
| Most Recent Dividend | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 04/04/24 | 05/16/24 | 03/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 6.43 | 14.24 | 10.02 | 23.79 |